Skip to main content

Morepen Laboratories Ltd

Stage 2 · Advancing · week 16Setup 7.9 ★★ GoodStrong +6.5

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States… More about the company

₹147
+2.09% today
₹8,053 Cr · Mid cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
0.0%
₹33.7 lo₹147 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 16
1w13w26w
Week 16 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
152.7%
200 DMA: ₹58.2 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.79x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +9.8% vs MA50 +33.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+29.2%
3M
+149.3%
6M
+282.4%
YTD
+247.7%
1Y
+205.7%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #3 of 77 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #3 of 61 Stage 2 stocks in this industry. Top tier.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 14w
S2 16w
S2 24w
S4 36w
S2 16w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 3w → S2 14w → S3 3w → S2 16w → S3 11w → S2 24w → S3 12w → S4 12w → S1 12w → S4 36w → S1 9w → S2 16w current
Total tracked: 169 weeks across 12 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Pullback Hunter
Latest: 2026-08-12
60 appearances in last 60 days. First seen: 2026-07-21.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 16 · Vol 0.79x
2026-10-06S2
Wk 16 · Vol 0.90x
2026-10-05S2
Wk 16 · Vol 0.74x
2026-10-01S2
Wk 16 · Vol 1.57x
2026-09-30S2
Wk 15 · Vol 1.10x
2026-09-29S2
Wk 15 · Vol 0.54x
2026-09-28S2
Wk 15 · Vol 0.82x
2026-09-25S2
Wk 15 · Vol 0.39x
2026-09-24S2
Wk 15 · Vol 0.39x
2026-09-23S2
Wk 14 · Vol 0.48x
2026-09-22S2
Wk 14 · Vol 0.44x
2026-09-21S2
Wk 14 · Vol 0.72x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹101.2
200 DMA
₹58.2
52W High
₹147
52W Low
₹33.7
5D Low
₹126
Resistance levels (recent highs)
20d High
₹147
60d High
₹147
120d High
₹147
250d High
₹147
Next resistance
Above all
P/E (TTM)
23.5
Forward —
Earnings Growth (YoY)
+2.0%
Revenue +5.7%
Dividend Yield
0.46%
P/B 1.9
About this companyHealth Care· Pharmaceuticals

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.